Lynn A. Tetrault
Director at Neogenomics Inc (NEO); Director at Rhythm Pharmaceuticals, Inc. (RYTM)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $3.8M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jun 24SEC | RYTMRhythm Pharmaceuticals, Inc. | Sell Plan | 37,0007,000 held (−84%) | $100.32 | $3.7M | -14.1% |
| Jun 17SEC | NEONeogenomics Inc | Sell Plan | 5,30786,115 held (−6%) | $11.10 | $59K | +50.0% |
| Jun 11SEC | NEONeogenomics Inc | Sell Plan | 5,30791,422 held (−5%) | $11.29 | $60K | +47.5% |
- Sell
Director Lynn A. Tetrault sold $3.7M of RYTM at $100.32 — cuts the stake by 84%; pre-scheduled 10b5-1 plan sale.
- Sell
Director Lynn A. Tetrault sold $59K of NEO at $11.10 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Lynn A. Tetrault sold $60K of NEO at $11.29 — pre-scheduled 10b5-1 plan sale.